AI-Designed Drugs Break Through Barriers in Cancer and Alzheimer’s Treatment Researchers are now leveraging AI to design drugs that target the so-called “undruggable” proteins, unstable, shifting molecules that have evaded traditional therapies for decades. Why Protein Shape M... AI drug design Alzheimer's research biotechnology cancer therapy intrinsically disordered proteins medical innovation protein binders synthetic biology
Yale’s Antibody-RNA Therapy: Tackling Treatment Resistant Cancers Recent advances at Yale are reshaping the fight against some of the toughest cancers. Researchers have engineered a unique antibody-RNA therapy that offers renewed hope for patients where traditional ... antibody-RNA cancer therapy clinical trials immunotherapy precision medicine resistant tumors Yale research